SHANDONG XINHUA PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 719 for the last quarter is 2.67 B HKD, and it's 55.50% higher compared to the previous quarter. The net income of Q1 24 is 154.36 M HKD.